nodes	percent_of_prediction	percent_of_DWPC	metapath
Ximelagatran—CYP2C9—Trimethadione—epilepsy syndrome	0.138	0.17	CbGbCtD
Ximelagatran—CYP2C9—Fosphenytoin—epilepsy syndrome	0.13	0.16	CbGbCtD
Ximelagatran—CYP2C9—Carbamazepine—epilepsy syndrome	0.093	0.115	CbGbCtD
Ximelagatran—CYP2C9—Primidone—epilepsy syndrome	0.0869	0.107	CbGbCtD
Ximelagatran—CYP2C9—Phenytoin—epilepsy syndrome	0.0835	0.103	CbGbCtD
Ximelagatran—CYP2C9—Propofol—epilepsy syndrome	0.0778	0.0962	CbGbCtD
Ximelagatran—CYP2C9—Phenobarbital—epilepsy syndrome	0.0744	0.0919	CbGbCtD
Ximelagatran—CYP2C9—Diazepam—epilepsy syndrome	0.0705	0.0872	CbGbCtD
Ximelagatran—CYP2C9—Valproic Acid—epilepsy syndrome	0.0556	0.0687	CbGbCtD
Ximelagatran—F2—forelimb—epilepsy syndrome	0.0046	0.621	CbGeAlD
Ximelagatran—F2—spinal cord—epilepsy syndrome	0.000672	0.0906	CbGeAlD
Ximelagatran—F2—head—epilepsy syndrome	0.000597	0.0805	CbGeAlD
Ximelagatran—F2—nervous system—epilepsy syndrome	0.000566	0.0764	CbGeAlD
Ximelagatran—F2—central nervous system—epilepsy syndrome	0.000545	0.0735	CbGeAlD
Ximelagatran—F2—brain—epilepsy syndrome	0.000433	0.0584	CbGeAlD
Ximelagatran—F2—Signaling by GPCR—GAL—epilepsy syndrome	0.000151	0.00082	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—GABBR1—epilepsy syndrome	0.00015	0.000817	CbGpPWpGaD
Ximelagatran—CYP2C9—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	0.00015	0.000814	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GRM5—epilepsy syndrome	0.000149	0.000811	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CHRM3—epilepsy syndrome	0.000149	0.000811	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR10—epilepsy syndrome	0.000147	0.0008	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—HRH3—epilepsy syndrome	0.000144	0.000783	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.000143	0.000778	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—CYP2D6—epilepsy syndrome	0.000142	0.000775	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.000142	0.000771	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—CDC42—epilepsy syndrome	0.000141	0.000767	CbGpPWpGaD
Ximelagatran—CYP2C9—Metapathway biotransformation—CYP2D6—epilepsy syndrome	0.00014	0.000765	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.00014	0.000763	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.00014	0.000763	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.00014	0.000763	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CHRM2—epilepsy syndrome	0.00014	0.000763	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—BCHE—epilepsy syndrome	0.000138	0.000751	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—GABBR1—epilepsy syndrome	0.000136	0.000742	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCR3—epilepsy syndrome	0.000134	0.000728	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	0.000133	0.000725	CbGpPWpGaD
Ximelagatran—CYP2C9—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	0.000131	0.000715	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HRH3—epilepsy syndrome	0.000131	0.000711	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—NPY—epilepsy syndrome	0.00013	0.00071	CbGpPWpGaD
Ximelagatran—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	0.00013	0.000709	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCR5—epilepsy syndrome	0.00013	0.000706	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—OPRM1—epilepsy syndrome	0.000129	0.0007	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GRM2—epilepsy syndrome	0.000128	0.000699	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	0.000128	0.000698	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—HTR2A—epilepsy syndrome	0.000127	0.000691	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—OXT—epilepsy syndrome	0.000126	0.000685	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CRH—epilepsy syndrome	0.000126	0.000685	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.000126	0.000685	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—FYN—epilepsy syndrome	0.000125	0.000683	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	0.000123	0.000671	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCR3—epilepsy syndrome	0.000121	0.000661	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—YWHAZ—epilepsy syndrome	0.000121	0.000656	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—AGT—epilepsy syndrome	0.00012	0.000655	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—PLAUR—epilepsy syndrome	0.00012	0.000653	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—NPY—epilepsy syndrome	0.000118	0.000644	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SSTR3—epilepsy syndrome	0.000116	0.000632	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CRH—epilepsy syndrome	0.000114	0.000622	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL3—epilepsy syndrome	0.000114	0.000622	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000114	0.000622	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—OXT—epilepsy syndrome	0.000114	0.000622	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—SST—epilepsy syndrome	0.000114	0.000619	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000114	0.000619	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000114	0.000619	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	0.000113	0.000617	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.000112	0.00061	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000111	0.000606	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR9—epilepsy syndrome	0.000111	0.000606	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR8—epilepsy syndrome	0.000111	0.000606	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NPY2R—epilepsy syndrome	0.000111	0.000606	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SSTR1—epilepsy syndrome	0.000111	0.000606	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000111	0.000606	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	0.00011	0.000601	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GRM3—epilepsy syndrome	0.000109	0.000594	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GRM4—epilepsy syndrome	0.000109	0.000594	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CA13—epilepsy syndrome	0.000109	0.000591	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SSTR2—epilepsy syndrome	0.000107	0.000583	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DUSP4—epilepsy syndrome	0.000107	0.000583	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PLAU—epilepsy syndrome	0.000107	0.000583	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000107	0.000582	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000107	0.000582	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000105	0.000571	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000105	0.000569	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PGF—epilepsy syndrome	0.000103	0.000564	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GRM8—epilepsy syndrome	0.000103	0.000564	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCR2—epilepsy syndrome	0.000103	0.000562	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—SST—epilepsy syndrome	0.000103	0.000562	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000102	0.000557	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—POMC—epilepsy syndrome	0.000101	0.000552	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000101	0.00055	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—PRKCB—epilepsy syndrome	9.95e-05	0.000542	CbGpPWpGaD
Ximelagatran—F2—GPCR ligand binding—CCL2—epilepsy syndrome	9.91e-05	0.00054	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—OPRD1—epilepsy syndrome	9.87e-05	0.000538	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GNAO1—epilepsy syndrome	9.87e-05	0.000538	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—NOS2—epilepsy syndrome	9.83e-05	0.000535	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT3—epilepsy syndrome	9.75e-05	0.000531	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—BDKRB2—epilepsy syndrome	9.71e-05	0.000529	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CXCL12—epilepsy syndrome	9.71e-05	0.000529	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CNR1—epilepsy syndrome	9.53e-05	0.000519	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PLCB1—epilepsy syndrome	9.49e-05	0.000517	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CHRM1—epilepsy syndrome	9.46e-05	0.000515	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GRM1—epilepsy syndrome	9.46e-05	0.000515	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PDYN—epilepsy syndrome	9.46e-05	0.000515	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR7—epilepsy syndrome	9.46e-05	0.000515	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HTR7—epilepsy syndrome	9.3e-05	0.000506	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HBEGF—epilepsy syndrome	9.02e-05	0.000491	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CDC42—epilepsy syndrome	8.9e-05	0.000485	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GFAP—epilepsy syndrome	8.9e-05	0.000485	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GAL—epilepsy syndrome	8.9e-05	0.000485	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT3—epilepsy syndrome	8.86e-05	0.000482	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GRM5—epilepsy syndrome	8.8e-05	0.000479	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CHRM3—epilepsy syndrome	8.8e-05	0.000479	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CASP2—epilepsy syndrome	8.8e-05	0.000479	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	8.74e-05	0.000476	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AVP—epilepsy syndrome	8.62e-05	0.000469	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—AGT—epilepsy syndrome	8.47e-05	0.000461	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CX3CR1—epilepsy syndrome	8.44e-05	0.000459	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CHRM2—epilepsy syndrome	8.27e-05	0.00045	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—BDKRB1—epilepsy syndrome	8.27e-05	0.00045	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CX3CL1—epilepsy syndrome	8.27e-05	0.00045	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—ALB—epilepsy syndrome	8.26e-05	0.00045	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PDXK—epilepsy syndrome	8.23e-05	0.000448	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—FAR1—epilepsy syndrome	8.23e-05	0.000448	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CERS1—epilepsy syndrome	8.23e-05	0.000448	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ADK—epilepsy syndrome	8.23e-05	0.000448	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	8.23e-05	0.000448	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	8.23e-05	0.000448	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CDC42—epilepsy syndrome	8.08e-05	0.00044	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—GABBR1—epilepsy syndrome	8.05e-05	0.000438	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AVP—epilepsy syndrome	7.82e-05	0.000426	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HRH3—epilepsy syndrome	7.72e-05	0.00042	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—OPRM1—epilepsy syndrome	7.6e-05	0.000414	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	7.53e-05	0.00041	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GAMT—epilepsy syndrome	7.53e-05	0.00041	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	7.53e-05	0.00041	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PNPO—epilepsy syndrome	7.53e-05	0.00041	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—CCR5—epilepsy syndrome	7.33e-05	0.000399	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR3—epilepsy syndrome	7.17e-05	0.000391	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—HTR2A—epilepsy syndrome	7.17e-05	0.00039	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—POMC—epilepsy syndrome	7.13e-05	0.000388	CbGpPWpGaD
Ximelagatran—F2—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	7.05e-05	0.000384	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CA4—epilepsy syndrome	7e-05	0.000381	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—QDPR—epilepsy syndrome	7e-05	0.000381	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ATP2A2—epilepsy syndrome	6.99e-05	0.000381	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NPY—epilepsy syndrome	6.99e-05	0.000381	CbGpPWpGaD
Ximelagatran—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	6.98e-05	0.00038	CbGpPWpGaD
Ximelagatran—F2—Metabolism of proteins—CCL2—epilepsy syndrome	6.97e-05	0.00038	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AGT—epilepsy syndrome	6.8e-05	0.00037	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL2—epilepsy syndrome	6.74e-05	0.000367	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL3—epilepsy syndrome	6.74e-05	0.000367	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CRH—epilepsy syndrome	6.74e-05	0.000367	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—OXT—epilepsy syndrome	6.74e-05	0.000367	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HSPB1—epilepsy syndrome	6.74e-05	0.000367	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCR5—epilepsy syndrome	6.65e-05	0.000362	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—COX3—epilepsy syndrome	6.58e-05	0.000358	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—HTR2A—epilepsy syndrome	6.51e-05	0.000355	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—PRKCB—epilepsy syndrome	6.29e-05	0.000342	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TSC1—epilepsy syndrome	6.27e-05	0.000341	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PTK2B—epilepsy syndrome	6.27e-05	0.000341	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	6.24e-05	0.00034	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	6.24e-05	0.00034	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PFKL—epilepsy syndrome	6.24e-05	0.00034	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	6.24e-05	0.00034	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	6.24e-05	0.00034	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AGT—epilepsy syndrome	6.18e-05	0.000336	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NTRK2—epilepsy syndrome	6.1e-05	0.000332	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SST—epilepsy syndrome	6.1e-05	0.000332	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR2—epilepsy syndrome	6.1e-05	0.000332	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	6.1e-05	0.000332	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	6.06e-05	0.00033	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—DUSP6—epilepsy syndrome	6.05e-05	0.000329	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ADRA2A—epilepsy syndrome	5.97e-05	0.000325	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PLAT—epilepsy syndrome	5.94e-05	0.000324	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—SRC—epilepsy syndrome	5.84e-05	0.000318	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—BDKRB2—epilepsy syndrome	5.73e-05	0.000312	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CXCL12—epilepsy syndrome	5.73e-05	0.000312	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—POMC—epilepsy syndrome	5.73e-05	0.000312	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—PRKCB—epilepsy syndrome	5.71e-05	0.000311	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ATIC—epilepsy syndrome	5.7e-05	0.000311	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—UPB1—epilepsy syndrome	5.7e-05	0.000311	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NEU1—epilepsy syndrome	5.7e-05	0.000311	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—VEGFA—epilepsy syndrome	5.69e-05	0.00031	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—IL6ST—epilepsy syndrome	5.69e-05	0.00031	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CNR1—epilepsy syndrome	5.63e-05	0.000307	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JUNB—epilepsy syndrome	5.63e-05	0.000307	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PLCB1—epilepsy syndrome	5.61e-05	0.000305	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	5.49e-05	0.000299	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HTR7—epilepsy syndrome	5.49e-05	0.000299	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HBEGF—epilepsy syndrome	5.33e-05	0.00029	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	5.3e-05	0.000289	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GBE1—epilepsy syndrome	5.3e-05	0.000289	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT3—epilepsy syndrome	5.23e-05	0.000285	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—POMC—epilepsy syndrome	5.2e-05	0.000283	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	5.18e-05	0.000282	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—ADAM10—epilepsy syndrome	5.11e-05	0.000278	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—CCL2—epilepsy syndrome	5.09e-05	0.000277	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	4.99e-05	0.000272	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	4.85e-05	0.000264	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—S100B—epilepsy syndrome	4.83e-05	0.000263	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SOCS3—epilepsy syndrome	4.79e-05	0.000261	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CDC42—epilepsy syndrome	4.77e-05	0.00026	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—NT5E—epilepsy syndrome	4.73e-05	0.000257	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALAD—epilepsy syndrome	4.73e-05	0.000257	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AVP—epilepsy syndrome	4.62e-05	0.000252	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	4.51e-05	0.000246	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	4.51e-05	0.000246	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	4.41e-05	0.00024	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HES1—epilepsy syndrome	4.37e-05	0.000238	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ADSL—epilepsy syndrome	4.32e-05	0.000235	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FYN—epilepsy syndrome	4.25e-05	0.000231	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GLUL—epilepsy syndrome	4.24e-05	0.000231	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—H2AFX—epilepsy syndrome	4.23e-05	0.000231	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MEF2C—epilepsy syndrome	4.23e-05	0.00023	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	4.16e-05	0.000227	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—YWHAZ—epilepsy syndrome	4.09e-05	0.000222	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—NGF—epilepsy syndrome	4.04e-05	0.00022	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCR5—epilepsy syndrome	3.93e-05	0.000214	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	3.89e-05	0.000212	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—HTR2A—epilepsy syndrome	3.85e-05	0.000209	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AQP1—epilepsy syndrome	3.78e-05	0.000206	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—TSC2—epilepsy syndrome	3.65e-05	0.000199	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AGT—epilepsy syndrome	3.65e-05	0.000199	CbGpPWpGaD
Ximelagatran—F2—Hemostasis—AKT1—epilepsy syndrome	3.63e-05	0.000198	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.63e-05	0.000198	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—APOE—epilepsy syndrome	3.58e-05	0.000195	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—KDR—epilepsy syndrome	3.5e-05	0.000191	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	3.42e-05	0.000186	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	3.42e-05	0.000186	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—PRKCB—epilepsy syndrome	3.37e-05	0.000184	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—IL6ST—epilepsy syndrome	3.36e-05	0.000183	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.18e-05	0.000173	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.12e-05	0.00017	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—POMC—epilepsy syndrome	3.07e-05	0.000167	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CCL2—epilepsy syndrome	3.01e-05	0.000164	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.79e-05	0.000152	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—FGF2—epilepsy syndrome	2.72e-05	0.000148	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.72e-05	0.000148	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.7e-05	0.000147	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.68e-05	0.000146	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—RELA—epilepsy syndrome	2.52e-05	0.000137	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MTOR—epilepsy syndrome	2.47e-05	0.000135	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.44e-05	0.000133	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.44e-05	0.000133	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	2.32e-05	0.000126	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—BCHE—epilepsy syndrome	2.31e-05	0.000126	CbGpPWpGaD
Ximelagatran—F2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.3e-05	0.000125	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—CASP3—epilepsy syndrome	2.27e-05	0.000124	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—JUN—epilepsy syndrome	2.21e-05	0.00012	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	2.2e-05	0.00012	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	2.18e-05	0.000119	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—TH—epilepsy syndrome	2.17e-05	0.000118	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—MMP9—epilepsy syndrome	2.15e-05	0.000117	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.14e-05	0.000116	CbGpPWpGaD
Ximelagatran—F2—Signaling by GPCR—AKT1—epilepsy syndrome	2.08e-05	0.000114	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—SRC—epilepsy syndrome	1.98e-05	0.000108	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—VEGFA—epilepsy syndrome	1.93e-05	0.000105	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.81e-05	9.86e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.79e-05	9.73e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.74e-05	9.47e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.62e-05	8.8e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.42e-05	7.72e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.39e-05	7.56e-05	CbGpPWpGaD
Ximelagatran—F2—Signaling Pathways—AKT1—epilepsy syndrome	1.23e-05	6.71e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.19e-05	6.5e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.09e-05	5.92e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	9.52e-06	5.18e-05	CbGpPWpGaD
Ximelagatran—CYP2C9—Metabolism—AKT1—epilepsy syndrome	4.78e-06	2.6e-05	CbGpPWpGaD
